MedTrace Logo

Improvement of Left Ventricular Ejection Fraction in ICD Patients Undergoing Therapy With Sacubitril/Valsartan

NCT03935087 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-05-02

No results posted yet for this study

Summary

The study is aimed to evaluate the improvement of the left ventricular volumes and of the left ventricular ejection fraction in a population of ICD patients with heart failure and left ventricle systolic dysfunction undergoing therapy with Sacubitril/Valsartan (according to current Guidelines), during a 6-month follow-up.

Conditions

Interventions

DIAGNOSTIC_TEST

two-dimensional echocardiogram

two-dimensional echocardiogram with evaluation of left ventricle volumes and of left ventricular ejection fraction

Sponsors & Collaborators

  • Azienda Ospedaliera Cardinale G. Panico

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-05-31
Completion
2019-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03935087 on ClinicalTrials.gov